News Release

First 'pathoconnectome' could point toward new treatments for neurodegenerative diseases

The pathoconnectome can be used to identify potential new treatments for neurodegenerative diseases, including epilepsy and Alzheimer's, by showing how they rewire neural systems

Peer-Reviewed Publication

University of Utah Health

2-D pathoconnectome image: Rod bipolar cell dendrites

image: A 2-D pathoconnectome image shows rod bipolar cell dendrites and their synapse locations with rod (red), cone (blue), and indeterminate (yellow) photoreceptors. view more 

Credit: John A. Moran Eye Center

SALT LAKE CITY--Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons.

Moran's Marclab for Connectomics was the first to complete a map of the circuitry of the retina, or connectome, in 2011. Now, the National Institutes of Health (NIH)-funded lab has produced the first pathoconnectome, showing how eye disease alters retinal circuitry.

The implications of the published research, A pathoconnectome of early neurodegeneration: Network changes in retinal degeneration, extend far beyond eye diseases. The eye holds lessons applicable to a host of neurodegenerative diseases including Alzheimer's, Parkinson's, epilepsy, and Lou Gehrig's disease.

"The components of neurodegeneration we see in the eye seem to mimic those we see in the brain," explained the paper's lead author, Moran's Rebecca L. Pfeiffer, PhD. "So this pathoconnectome is allowing us to learn fundamental rules of how neurodegenerative diseases alter neural networks in general. The ultimate goal is to identify how we might develop new therapies based on preventing or interfering with the network rewiring prompted by disease."

The Marclab developed the pathoconnectome from a model of early-stage retinitis pigmentosa (RP), an inherited retinal disease that can lead to blindness. The immense data set compiled to construct the pathoconnectome has taken years to assemble and is open for use by other scientists. The Marclab is working on a second and third pathoconnectome that will show how the retina rewires itself in later stages of RP.


In addition to Pfeiffer, 12 other Marclab researchers are authors on the publication: James R. Anderson, PhD; Jeebika Dahal; Jessica C. Garcia; Jia-Hui Yang; Crystal L. Sigulinsky PhD; Kevin Rapp; Daniel P. Emrich; Carl B. Watt, PhD; Hope AB Johnstun; Alexis R. Houser; Robert E. Marc, PhD; and lab director Bryan W. Jones, PhD.

The Marclab constructed the pathoconnectome by studying 946 tissue sections with two transmission electron microscopes, which work nonstop nearly every day of the year to produce an unprecedented amount of data to understand retinal circuitry. In 2018, the Lawrence T. and Janet T. Dee Foundation generously funded the lab's second transmission electron microscope. The first was provided by Moran donor Martha Ann Dumke Healy.

Watch a video to learn more about the pathoconnectome.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.